Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

Hyderabad (Telangana) [India], February 25 (ANI): Biological E Limited (BE) on Tuesday announced a strategic partnership with ...

Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

The partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...

Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...

Hyderabad-based Biological E. Limited (BE) is partnering with Danish firm Bavarian Nordic to expand access to the latter’s ...

The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...